Research Solutions (NASDAQ:RSSS - Get Free Report) is anticipated to release its Q3 2025 earnings data after the market closes on Thursday, May 8th. Analysts expect the company to announce earnings of $0.03 per share and revenue of $13.02 million for the quarter.
Research Solutions (NASDAQ:RSSS - Get Free Report) last released its quarterly earnings results on Thursday, February 13th. The company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.09). The firm had revenue of $11.91 million for the quarter, compared to analyst estimates of $11.86 million. Research Solutions had a negative return on equity of 6.59% and a negative net margin of 8.41%. On average, analysts expect Research Solutions to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Research Solutions Stock Down 0.4 %
Shares of RSSS stock traded down $0.01 during trading hours on Tuesday, reaching $2.80. The company's stock had a trading volume of 1,810 shares, compared to its average volume of 89,116. The company has a market capitalization of $91.41 million, a price-to-earnings ratio of -18.67, a PEG ratio of 4.33 and a beta of 0.66. The firm's 50 day simple moving average is $2.71 and its 200-day simple moving average is $3.23. Research Solutions has a fifty-two week low of $2.32 and a fifty-two week high of $4.24.
About Research Solutions
(
Get Free Report)
Research Solutions, Inc, through its subsidiaries, provides research cloud-based software-as-a-service software platform and related services to corporate, academic, government and individual researchers in the United States, Europe, and internationally. It provides Discover platform that facilitates search discovery across virtually all scientific, technical, and medical (STM) articles available, including free basic search solutions and advanced search tools, which include the Resolute.ai and scite.ai products, a tools that allows for searching and identifying relevant research and find insights in other datasets adjacent to STM content, such as clinical trial, patent, life science and medtech regulatory information, competitor and technology landscape insights in addition to searching the customer's internal datasets.
Further Reading
Before you consider Research Solutions, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Research Solutions wasn't on the list.
While Research Solutions currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
